Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment

Documenti analoghi

• Newer glucose‐lowering drugs and risk of suicidal ideation and behaviours: A network meta‐analysis of randomized outcome trials
  di: Ying Lu, et al.
  Pubblicazione: (2024)
• Assessing the benefit–risk profile of newer glucose‐lowering drugs: A systematic review and network meta‐analysis of randomized outcome trials
  di: Huilin Tang, et al.
  Pubblicazione: (2024)
• Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
  di: Tahmid Hussain, et al.
  Pubblicazione: (2026)
• Sodium‐glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real‐world patients with type 2 diabetes
  di: Jingchuan Guo, et al.
  Pubblicazione: (2024)
• Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
  di: Howard Wolpert, et al.
  Pubblicazione: (2025)